ǰÑÔ
½ÇĤ¼²²¡(cornea disease)¶ÔÊÓÁ¦µÄΣº¦ÐԺܴó£¬ÖÖÖÖ½ÇĤ¼²²¡ÒýÆð½ÇĤµÄ»ì×ÇÊÇÖÂäµÄÖ÷ÒªÔµ¹ÊÔÓÉÖ®Ò»¡£ÏÖÔÚÎÒ¹úÖÚ¶àÖÂäµÄ¼²²¡ÖУ¬½ÇĤ¼²²¡½ö´ÎÓÚ°×ÄÚÕÏλ¾ÓµÚ¶þ¡£½ÇĤ¼²²¡Ö÷Òª°üÀ¨½ÇĤµÄÑ×Ö¢¡¢ÍâÉË¡¢ÏÈÌìÐÔÒì³£¡¢±äÐÔ¡¢ÓªÑø²»Á¼¼°Ö×ÁöµÈ¡£ÆäÖÐѬȾÐÔ½ÇĤÑ×ÔÚÁÙ´²ÉϸüΪ¶à¼û£¬¾ßÓÐÖ÷ÒªÒâÒå¡£ÔöÇ¿½ÇĤ¼²²¡µÄ·ÀÖÎÑо¿ÒѳÉΪïÔÌÒò½ÇĤ¼²²¡ÖÂäµÄÖ÷Òª²½·¥¡£
½áĤÊÇÒ»²ã°ë͸Ã÷µÄð¤Ä¤£¬ÓÉÑÛíúÔµ¼ä²¿×îÏÈÁýÕÖÓÚÑÛíúºóºÍÑÛÇòǰ£¬¿É·ÖΪÉÏÆ¤²ãºÍð¤Ä¤Ï»ùÖʲ㡣½áĤÉÏÆ¤ÅþÁÚÓÚ½ÇĤÉÏÆ¤£¬Òò´Ë½ÇĤ¡¢½áĤ¼²²¡ÈÝÒ×Ï໥ӰÏì¡£½ÇĤµÄ´ó²¿·ÖÍâò̻¶ÓÚÍâ½ç£¬Óë¶àÖÖÖ²¡ÒòËØÏà½Ó´¥¡£µ±ÑÛ±íµÄÌØÒìÐԺͷÇÌØÒìÐÔ·ÀÓù»úÖÆ¼õÍË»òÍâ½çÖ²¡ÒòËØÔöǿʱ£¬½«ÒýÆð½áĤ×éÖ¯µÄ¼²²¡¡£ÆäÖнáĤÑ×ÊÇÑÛ¿Æ×î³£¼ûµÄ¼²²¡Ö®Ò»¡£
ƾ֤¼²²¡ÀàÐÍ£¬³£¼û½ÇĤ¡¢½áĤ¼²²¡¶¯ÎïÄ£×Ó°üÀ¨½Ç½áĤÑ×Ä£×Ó¡¢½ÇĤËðÉËÄ£×Ó¡¢½ÇĤÐÂÉúѪ¹ÜÄ£×Ó¼°¸ÉÑÛ²¡Ä£×ӵȡ£
ƾ֤²¡ÒòµÄ²î±ð£¬½Ç½áĤÑ×(kerato conjunctivitis) °üÀ¨Î¢ÉúÎïÐԺͷÇ΢ÉúÎïÐÔÁ½´óÀà¡£ÆäÖÐ΢ÉúÎïÐԽǽáĤÑ×ÊÇ×î³£¼ûµÄ£¬°üÀ¨Ï¸¾úÐÔ¡¢²¡¶¾ÐÔ¡¢Õæ¾úÐÔ¼°Å¼¼ûµÄ¼ÄÉú³æÐÔ¡£·Ç΢ÉúÎïÐԽǽáĤÑ×°üÀ¨ÎïÀíÐÔÒòËØ£¨×ÏÍâÏß¡¢·Û³¾µÈ£©¡¢»¯Ñ§ÐÔÒòËØ£¨Ò©Æ·¡¢Ëá¼î¡¢Óж¾ÆøÌåµÈ£©ºÍÃâÒßÐÔÒòËØÒýÆðµÄ½Ç½áĤÑ×Ö¢·´Ó¦¡£½Ç½áĤÑ×ÒýÆðµÄËðÉ˲»µ«Ó벡ÔÌåµÄѬȾ»òÆäËû²¡ÒòµÄ´Ì¼¤Óйأ¬Í¬Ê±Ò²ÓëËÞÖ÷µÄÃâÒß״̬Ç×½üÏà¹Ø¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯Î¼ÒÍÃ
¡¾ÔìÄ£»úÖÆ¡¿£º
½ÇĤʵÖʲãÕ¼½ÇĤºñ¶È90£¥£¬ÓÉ100~200²ãÅÅÁйæÔòµÄ½ºÔÏËά×é³É£¬½ÇĤ°å²ãÏËά֮¼äÓÐÉÙÁ¿µÄ½ÇĤ¹ÌÓÐϸ°û¡£µ±½ÇĤËðÉ˺ÍÑ×֢ʱ£¬¿ÉÓÕʹÕâЩϸ°ûÑݱäΪ³ÉÏËάϸ°û£¬¼ÓÈëËðÉ˲¿Î»µÄÐÞ¸´¡£½ÇĤÎÞѪ¹Ü£¬ÆäÓªÑøÈªÔ´ÓÚ·¿Ë®¡¢ÀáĤºÍ½ÇĤԵëϸѪ¹Ü¡£Ï¸¾úÐÔ½ÇĤÑ×(bacterial keratitis)Ñ×Ö¢ÆÚËðÉ˲¿Î»µÄÉÏÆ¤²ã¼°ÊµÖʲãϸ°ûÒà¿ÉÊͷųöÂѰ×Ë®½âø£¬µ¼ÖÂÀ£Ññ±äÉîºÍÔö´ó¡£ÑÛ½áĤºÍÀáÏÙÒ²¼ÓÈëÑ×Ö¢·´Ó¦£¬ÌåÏÖ½áĤºìÖ׳äѪ£¬ÁܰÍϸ°û¡¢µ¥ºËϸ°û¡¢ÖÐÐÔÁ£Ï¸°ûÔö¶à£¬ÀáÒº¿É³åÏ´½áĤÄҺͽÇĤÍâò¡£ÀáÒºÖк¬ÓÐijЩ¿¹¾úÐÔÈܾúø¡¢ÃâÒßÇòÂѰ׾ßÓÐɱ¾ú×÷Óᣵ«»úÌåÐÞ¸´¿ìÂýÓë½ÇĤËðÉËÉîdz¡¢Ï¸¾ú¶¾Á¦Ç¿Èõ¡¢Ñ¬È¾Ï¸¾úÁ¿¼¸¶àÓйء£ÍÂ̼ٵ¥°û¾úÊÇÏÖÔÚÑÛ¿ÆÖ²¡ÐÔ½ÏÇ¿µÄϸ¾ú¡£ÓÉÓڸþú±¬·¢¶àÖÖÏûÈÚø¿ÉÒýÆð¾Ö²¿×éÖ¯µÄ½µ½â£¬µ¼Ö»úÌå¶Ôϸ¾ú±¬·¢Ñ×ÐÔ·´Ó¦£¬ÌåÏÖ½ÇĤ×éÖ¯ÆÆËðÉõÖÁ´©¿×¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
Ñ¡Óÿµ½¡¼ÒÍã¬ÌåÖØ2.0kg×óÓÒ£¬êòĵ²»ÏÞ¡£Ôìģǰ¾ÙÐÐÍâÑÛ¼ì²é£¬ÎÞÒì³£ÕßÓÃÓÚÔìÄ£¡£ÔìģǰÏȾÙÐÐϸ¾ú½ÓÖÖÒºµÄÖÆ±¸£¬½«4¡æ±ùÏäÉúÑĵÄÍÂ̼ٵ¥°û¾ú½ÓÖÖµ½Í¨Ë×ÇíÖ¬×÷Óý»ùÉÏ£¬36¡æÇéÐÎ×÷Óý24~48Сʱ£¬Óò¬½ð¶ú»·¹ÎϾúÂ䣬רÐÄÀíÑÎË®Åä³É2×109/mlŨ¶È£¨¹âµç±È×ÇÒDzⶨŨ¶È£©¡£Ôìģʱ£¬Óö¡¿¨Òò¶Ô¼ÒÍÃÑÛ¾ÙÐоֲ¿Çá¶ÈÂé×í£¬Óû·×êեȡ½ÇĤÎÞ·´Ó¦£¬ÏȺóÓÃ7mmºÍ4mmÖ±¾¶½ÇĤ»·×êÇáÇᰴѹ½ÇĤ˳ʱÕëÐýת£¬Ôì³É»·Ðδ´ÉË¡£À¿ªÑÛÁ³³É±ÐΣ¬ÓÃ1ml×¢ÉäÆ÷ÎüÊÕ2×109/ml¾úÒºµÎÓÚÍÃÑÛ0.1ml/ÑÛ£¬Ñ¬È¾µ¥ÑÛ¡£24СʱºóÊÓ²ìÑÛ²¿Ö¢×´²¢¾ÙÐÐÆÀ·Ö£¬Ò»Á¬ÊÓ²ì7Ìì¡£
0¼¶£ºÑÛÃ÷ÁÁÎÞÉøÍ¸Î0.5¼¶£ºÎÞÉøÍ¸ÎïÁýÕÖ£¬ÑÛÉÔÓкìÖ×£»1¼¶£ºÉøÍ¸ÎïÁýÕÖСÓÚ6mm;2¼¶£ºÉøÍ¸ÎïÁýÕÖ³äÂú6mm;3¼¶£ºÉøÍ¸ÎïÁýÕÖ´óÓÚ6mm¡£
ѬȾºóµÚ1¡¢3¡¢5ÌìÓÃÎÞ¾úÐÄÀíÑÎË®ÃÞǩȡѬȾÑۺͱÈÕÕÑÛÉøÍ¸Î»®·Ö·ÅÈë4mlÐÄÀíÑÎË®ÖлìÔÈ£¨´ý¼ìÒº£©¡£ÎüÊÕ1ml´ý¼ìÒº¼ÓÈëÎÞ¾ú×÷ÓýÃó(90mmÖ±¾¶£©£¬½«¼ÓÈÈÈÚ»¯ÔÙÀäÈ´ÖÁ45°C×óÓÒµÄÓªÑøÇíÖ¬µ¹Èë×÷ÓýÃó15ml£¬ÇáÇá˳ʱÕëÒ¡ÔÈ£¬´ýÀäÄýºóÖÃ36¡æ×÷ÓýÏä24Сʱ£¬ÅжÏϸ¾úÒõÑôÐÔ¡£
¡¾Ä£×ÓÌØµã¡¿£º
½ÓÖÖ24~48Сʱºó£¬»¼ÑÛ·ºÆð´óÁ¿Î¢»ÆÉ«ÉøÍ¸ÎÑÛ½áĤÑÏÖØ³äѪ£¬½ÇĤ»ì×Ç£¬Ë«ÑÛ½ô±Õ£¬Å§ÐÔÉøÍ¸ÎïʹÑÛÁ³Õ³Á¬£¬ÇáÇáÀ¿ªÍÃÑÛÉøÍ¸ÎïÁýÕÖÈ«½ÇĤ£¬ÏÕЩÎÞ·¨¿ú¼ûºçĤͫ¿×¡£µÚ5Ìì³ýÉÙÊýÑÛÆÀ·ÖΪ2.0¼¶Í⣬´ó¶¼¿É´ï3.0¼¶¡£Ï¸¾ú×÷ÓýЧ¹û£º½ÓÖÖºóµÚ1¡¢3¡¢5ÌìÉøÍ¸Îï×÷Óý¾ù³ÊÑôÐÔ¡£½ÇĤ²¡ÀíÇÐÆ¬ÏÔʾ£º½ÇĤ¸ß¶ÈË®Öס¢»ì×Ç£¬Ç°1/3»ùÖʿɼû´óÁ¿ÖÐÐÔÁ£Ï¸°û¡¢ÁܰÍϸ°û¡¢³ÉÏËάϸ°ûºÍ»µËÀ×éÖ¯¡£ÉÏÆ¤ÏÂÉË¿ÚÀ£ÑñδÓúºÏ¡£½ÇĤ»ùÖÊÖпɼûÐÂÉúѪ¹Ü£¬²¿·ÖÇÐÆ¬¿É¼û½ÇĤ´©¿×£¬Ç°·¿»ýŧ¡£ºçĤѪ¹ÜÀ©ÕÅ¡¢³äѪ²¢ÓдóÁ¿Ñ×ϸ°û½þÈó¡£
¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º
±¾ÒªÁì½ÓÄɽÇĤ»·×êÔì³É½ÇĤËðÉËÆä²Ù×÷¼òÆÓ£¬±ãÓÚÕÆÎÕ¡£µ«ÔìÄ£ÕßÊÖ·¨ µÄÇáÖØ²î±ð£¬»áÔì³É½ÇĤËðÉËÉîdz·×ÆçÖ£¬ÔÚʵÑé·Ö×éʱӦ°´ÆÀ·Ö±ê×¼ÔȳƷÖ×飬ʹÿ×鶯ÎïÄ£×ÓÑ×֢ˮƽÎÞÏÔ×Ųî±ð¡£±¾·¨½¨ÉèµÄ¶¯ÎïÄ£×ÓÊÊÓÃÁÙ´²¿¹¾úÒ©Îïɸѡ¡£
²Î¿¼ÎÄÏ×£º
1.ÇñÅàèª. ½ÇĤÐÂÉúѪ¹ÜµÄ¶¯ÎïÄ£×Ó£®ÍâÑóҽѧ£ºÑÛ¿ÆÑ§·Ö²á£¬2000, 24 (6):360-363
2.ºú¶«¶«£¬Íõ¼ÎÈÝ£¬ÑîÔÚ¸»£®¼¤¹âÑÛËðÉ˶¯ÎïУÐÍÑо¿Ï£Íû£®¾üÊÂҽѧ¿ÆÑ§ÔºÔº¿¯£¬2010,5:489-491
3.Äô°®ÇÛ£¬Ï¯Ã磬ϯÐË»ª£¬µÈ´¿´â°ÌÕ¶¾ÐÔ½ÇĤÑ×¢òÊóÄ£×ӵĽ¨Éè¼°ÅжϹú¼ÊÑÛ¿ÆÔÓÖ¾£¬2012,12(11): 2059-2061
4.ÐìÑÒ±äÓ¦ÐÔ½áĤÑ×¶¯ÎïÄ£×ÓÑÛ¿ÆÑо¿£¬2001, 19(2):181-183
5.κÈ𻪣¬ºÂÓÀÄÈ£¬ÕÔÉÙÕ꣮×ÔÉíÃâÒßÏà¹ØÐÔ¸ÉÑÛ¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÑÛ¿ÆÐÂÏ£Íû£¬2012, 32 (7):690-693
6.Calonge MC, Pastor JC, Herreras JM, el al. Pharmacologic modulation of vascular permeability in ocular allergy in the rat. Invest Ophthalmol Vis Sci, 1990, 31 (1): 176-180
7.Marquart ME.Animal models of bacterial keratitis.J Biomed Biotechnol,2011,2011:680642
8.Pavan-Langston D. Herpes simplex virus ocular infections:current concepts of acute, latent and reactivated disease. Trans Am Ophthalmol Soc, 1990,88:727-796